We are live on ! Find out more
CLDI icon

Calidi Biotherapeutics
CLDI

27 hedge funds and large institutions have $165M invested in Calidi Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.61% more ownership

Funds ownership: 0% → 0.61% (+0.61%)

Holders
27
Holders Change
+27
Holders Change %
–
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
–
Reduced
–
Closed
–
Calls
$594K
Puts
–
Net Calls
+$594K
Net Calls Change
+$594K

Top Buyers

Rank Fund Capital Flow
1
AMH
Apollo Management Holdings
New York
+$19.4M
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$19.4M
3
WP
Woodline Partners
California
+$19.4M
4
HCM
Highbridge Capital Management
New York
+$15.6M
5
DCM
Driehaus Capital Management
Illinois
+$14.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AMH
1
Apollo Management Holdings
New York
$19.4M +$19.4M +16,500 New
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$19.4M +$19.4M +16,500 New
WP
3
Woodline Partners
California
$19.4M +$19.4M +16,500 New
HCM
4
Highbridge Capital Management
New York
$15.5M +$15.6M +13,196 New
DCM
5
Driehaus Capital Management
Illinois
$14.7M +$14.7M +12,500 New
BCM
6
Beryl Capital Management
California
$11.4M +$11.4M +9,667 New
Marshall Wace
7
Marshall Wace
United Kingdom
$10.4M +$10.4M +8,852 New
GL
8
Governors Lane
New York
$9.82M +$9.82M +8,333 New
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$8.02M +$8.01M +6,798 New
PC
10
Periscope Capital
Ontario, Canada
$6.64M +$6.64M +5,633 New
SCM
11
Saba Capital Management
New York
$6.1M +$6.1M +5,179 New
SC
12
Sculptor Capital
New York
$4.91M +$4.91M +4,167 New
RCM
13
Radcliffe Capital Management
Pennsylvania
$3.93M +$3.93M +3,333 New
OCM
14
Oaktree Capital Management
California
$2.95M +$2.95M +2,500 New
WRBC
15
W.R. Berkley Corp
Connecticut
$2.31M +$2.31M +1,964 New
6CM
16
683 Capital Management
New York
$1.96M +$1.96M +1,667 New
WAM
17
Wolverine Asset Management
Illinois
$1.83M +$1.84M +1,558 New
SCM
18
Shaolin Capital Management
Florida
$1.72M +$1.72M +1,458 New
Deutsche Bank
19
Deutsche Bank
Germany
$981K +$982K +833 New
Goldman Sachs
20
Goldman Sachs
New York
$883K +$884K +750 New
PCM
21
Pinz Capital Management
New York
$559K +$560K +475 New
LA
22
Linden Advisors
New York
$492K +$491K +417 New
SCM
23
Segantii Capital Management
Hong Kong
$492K +$491K +417 New
AA
24
AQR Arbitrage
Connecticut
$412K +$412K +350 New
KKRC
25
Kohlberg Kravis Roberts & Co
New York
$260K +$260K +221 New
1
2

CLDI Hedge Fund Activity: Q4 2021 in Review

27 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Calidi Biotherapeutics (CLDI) for Q4 2021, worth a combined $165M.

Buyers outnumbered sellers: 27 funds opened new CLDI positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Apollo Management Holdings, opening a new position worth an estimated $19.4M.

  • 27 institutional investors held Calidi Biotherapeutics (CLDI) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $165M of Calidi Biotherapeutics stock for Q4 2021.
  • 27 funds opened new Calidi Biotherapeutics positions in Q4 2021 and 0 closed out, a net change of +27 holders.
  • The largest Calidi Biotherapeutics buyer in Q4 2021 was Apollo Management Holdings, an estimated $19.4M added.

Based on aggregated 13F filings for Q4 2021.